Alivus Life Sciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.41% vs 14.44% in Dec 2025

Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 8.25% vs 15.56% in Dec 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -7.24% vs 29.08% in Dec 2025

Interest

QoQ Growth in quarter ended Mar 2026 is -12.08% vs 12.88% in Dec 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Alivus Life With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

689.12

1,718.74

-1,029.62

-59.91%

Other Operating Income

0.00

Total Operating income

689.12

1,718.74

-1,029.62

-59.91%

Raw Material Cost

228.71

404.24

-175.53

-43.42%

Purchase of Finished goods

0.00

94.37

-94.37

-100.00%

(Increase) / Decrease In Stocks

42.14

16.32

25.82

158.21%

Employee Cost

78.12

407.03

-328.91

-80.81%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

125.62

522.71

-397.09

-75.97%

Total Expenditure (Excl Depreciation)

474.59

1,444.67

-970.08

-67.15%

Operating Profit (PBDIT) excl Other Income

214.53

274.07

-59.54

-21.72%

Other Income

22.78

25.88

-3.10

-11.98%

Operating Profit (PBDIT)

237.31

299.95

-62.64

-20.88%

Interest

1.31

19.42

-18.11

-93.25%

Exceptional Items

0.00

-24.76

24.76

100.00%

Gross Profit (PBDT)

236.00

255.77

-19.77

-7.73%

Depreciation

20.20

82.31

-62.11

-75.46%

Profit Before Tax

215.80

173.46

42.34

24.41%

Tax

53.14

-69.61

122.75

176.34%

Provisions and contingencies

0.00

Profit After Tax

162.66

243.07

-80.41

-33.08%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

162.66

243.07

-80.41

-33.08%

Equity Capital

24.55

39.31

-14.76

-37.55%

Face Value

2.00

0.00

Reserves

0.00

Earnings per share (EPS)

13.25

12.37

0.88

7.11%

Diluted Earnings per share

13.22

12.37

0.85

6.87%

Operating Profit Margin (Excl OI)

31.13%

15.95%

0.00

15.18%

Gross Profit Margin

34.25%

14.88%

0.00

19.37%

PAT Margin

23.60%

14.14%

0.00

9.46%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 689.12 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 2.41% vs 14.44% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 6.09% vs 21.05% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 162.66 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 8.25% vs 15.56% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 14.65% vs 44.85% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 214.53 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -7.24% vs 29.08% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 8.11% vs 40.30% in Mar 2025

Quarterly - Interest

Interest 1.31 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -12.08% vs 12.88% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 3.97% vs 250.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 31.13%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025